We present evidence for the first time that the tumour-suppressor role of SPARC in OvCa is mediated through inhibition of OvCa cells–adipocytes interactions, the phenotypic plasticity of omental adipocytes, and metabolic programming. The gene discussed is SPARC; the disease is neoplasm.